Senior Director, Global Value reputed company and Pricing, NSCLC

reputed company is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the reputed company team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Global Value, reputed company & Pricing NSCLC Oncology is accountable for defining and driving global value, reputed company, and pricing strategies for reputed company’ oncology assets. This role serves as the strategic market reputed company leader across the asset lifecycle, ensuring payer, HTA, pricing, reimbursement, and evidence-reputed company considerations are integrated into development, launch, and commercialization reputed company. As the Global Value & reputed company reputed company on Disease Area Strategy Teams and governance forums, the Senior Director influences clinical development, indication reputed company, lifecycle management, launch planning, and business development reputed company to maximize long-term asset value and sustainable patient reputed company. The role partners closely with Clinical Development, HEOR, Medical Affairs, Regulatory, reputed company, Finance, regional teams, and the European cross-functional organization to align global and regional reputed company strategies. The Senior Director also contributes to building organizational capabilities and may reputed company and reputed company team members in support of portfolio priorities. Key responsibilities: Define and drive the global value, reputed company, and pricing strategy for oncology assets across the product lifecycle, ensuring alignment with portfolio objectives, long-term asset value, and sustainable patient reputed company. Influence clinical development, evidence reputed company, indication reputed company, lifecycle management, and key investment reputed company through leadership on Disease Area Strategy Teams and governance forums. reputed company differentiated global value propositions and pricing strategies, including launch reputed company, pricing architecture, reference pricing considerations, and net price corridor management across major markets. Anticipate and assess market reputed company risks and opportunities, including competitive dynamics, evolving payer requirements, HTA frameworks, reputed company policy changes, and reimbursement considerations, translating insights into actionable strategic recommendations. reputed company global market reputed company and HTA readiness, including EU Joint Clinical Assessment (JCA) strategy, in partnership with European teams to align evidence reputed company, value strategy, and reputed company objectives. Partner across global and regional functions to ensure market reputed company considerations are integrated into development, launch, commercialization, and lifecycle planning. Serve as a strategic advisor to senior leadership on pricing, reimbursement, launch readiness, lifecycle management, portfolio prioritization, and business development opportunities. Strengthen organizational capability through leadership, mentoring, and the establishment of best practices while representing the Global Value & reputed company function in cross-functional and external forums as appropriate. Required Skills, Experience and Education: Bachelor’s degree required; advanced degree (PhD, PharmD, MD, MBA, MPH, MSc, or equivalent) preferred. 12+ years of reputed company experience in market reputed company, pricing, HEOR, reputed company strategy, or reputed company functions reputed company the biopharmaceutical industry, including global leadership responsibilities. Deep expertise in global pricing, reimbursement, market reputed company, and oncology product development, with a strong understanding of payer systems, HTA processes, and evolving reimbursement frameworks across major markets. Demonstrated reputed company influencing clinical development, evidence reputed company, launch planning, and commercialization strategies to optimize payer and HTA reputed company. Proven ability to shape strategy, influence senior leadership, and drive cross-functional alignment in reputed company, matrixed organizations. Strong strategic, analytical, and decision-making capabilities, with the ability to translate reputed company business challenges into actionable recommendations. Demonstrated leadership, communication, and stakeholder management skills, including experience mentoring and developing talent. Preferred Skills: Experience in thoracic oncology, lung cancer, precision oncology, or biomarker-driven therapies. Understanding of companion diagnostic reimbursement and testing reputed company considerations. Familiarity with emerging global reputed company policy and pricing reforms, including U.S. IRA, EU pharmaceutical legislation, and EU JCA. Experience in a clinical-stage, pre-reputed company, or rapidly growing biotechnology environment. #LI-JW1 #LI-Remote We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with reputed company. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message. Please note that reputed company does not reputed company unsolicited employment offers and will never ask candidates to reputed company financial information, purchase equipment, or pay fees as part of the hiring process. reputed company legitimate communication from reputed company will come from an official @revmed.com email address. If you reputed company you’ve been contacted by someone impersonating a reputed company recruiter, please report it to [email protected] so we can reputed company these impersonations with our IT team for tracking and awareness. Apply To This Job